ENXTPA:GFC
ENXTPA:GFCOffice REITs

Gecina (ENXTPA:GFC): Assessing Valuation After Recent Share Price Dip

Gecina (ENXTPA:GFC) has seen its share price dip about 1% today, a move that stands out given the company's performance this month. Investors seem curious about recent market shifts and what they might signal for the stock's outlook. See our latest analysis for Gecina. After several months of choppy trading, Gecina’s recent 1% slip comes as momentum continues to cool. Its 30-day share price return sits at -4.5%, and the total shareholder return over the last year is down more than 18%. While...
ENXTPA:NEX
ENXTPA:NEXElectrical

Could Nexans’ (ENXTPA:NEX) CEO Transition Reveal a New Chapter for Long-Term Strategy?

Earlier this week, Nexans S.A. announced a sudden leadership transition, with Julien Hueber appointed as Chief Executive Officer effective immediately, succeeding Christopher Guérin, who will remain available for the transition until October 31, 2025. This rapid executive change signals a fresh direction for the company, as the Board seeks to generate new momentum while building on recent achievements in sustainable electrification. We'll explore how Julien Hueber's appointment as CEO could...
ENXTPA:ALMEX
ENXTPA:ALMEXTelecom

Mexedia (ENXTPA:ALMEX) Discounted vs Peers, But 5-Year Losses Challenge Value Narrative

Mexedia Società Per Azioni S.B (ENXTPA:ALMEX) is trading at a Price-To-Sales Ratio of 1.2x, which is below its peer average of 2.1x and aligns with the broader European Telecom industry. Despite this apparent value, the company remains unprofitable, with losses widening at an average annual rate of 84.1% over the past five years. Margins have not improved, and ongoing instability in the share price means profitability remains elusive for investors looking for a sustained turnaround. See our...
ENXTPA:NEX
ENXTPA:NEXElectrical

Nexans (ENXTPA:NEX): Evaluating Valuation in Light of Sudden CEO Transition and Investor Uncertainty

Nexans (ENXTPA:NEX) shares slid over 9% after the company named Julien Hueber as its new CEO, replacing Christopher Guérin with immediate effect. The sudden executive change has sparked widespread investor discussion about the company’s next steps and long-term strategy. See our latest analysis for Nexans. The CEO shake-up at Nexans came shortly after a notable Innovation Summit focused on grid modernization and digitalization. This event had positioned the company at the center of energy...
ENXTPA:DG
ENXTPA:DGConstruction

European Dividend Stocks To Watch Now

As European markets experience a pullback from record highs amid political turmoil in France and ongoing international trade tensions, investors are paying close attention to dividend stocks for their potential stability and income generation. In such uncertain times, a good dividend stock is often characterized by its consistent payout history and the financial strength to maintain dividends even when broader market conditions are challenging.
ENXTPA:MMT
ENXTPA:MMTMedia

Evaluating M6 Group (ENXTPA:MMT): Is There Upside Left After Recent Slowdown?

Métropole Télévision (ENXTPA:MMT) stock has seen some attention from investors recently, as performance metrics across the past month and three months show declines. At the same time, its year-to-date returns remain in positive territory. Market watchers are curious about what is driving this contrast. See our latest analysis for Métropole Télévision. This year’s story for Métropole Télévision has been one of solid progress, with its share price holding above €12 and its year-to-date share...
ENXTPA:NANO
ENXTPA:NANOBiotechs

Nanobiotix (ENXTPA:NANO): Valuation Update Following Promising Clinical Data and Strong Financial Results

Nanobiotix (ENXTPA:NANO) is drawing a lot of market attention following the recent presentation of encouraging Phase 1 clinical data for JNJ-1900 (NBTXR3) in both esophageal and head and neck cancers. The timing comes at the same time as improvements in the company’s interim financial results, raising questions about future growth potential. See our latest analysis for Nanobiotix. Nanobiotix’s latest clinical breakthroughs and a turnaround in financial performance have supercharged momentum,...
ENXTPA:ENX
ENXTPA:ENXCapital Markets

Is Euronext Fairly Priced After Recent Market Rally in 2025?

Thinking about what to do with your Euronext shares? You are not alone. Whether you are weighing a new investment or simply tracking your returns, it is hard to ignore how this stock has made waves on the market. Euronext is up just over 19% year-to-date and has soared more than 31% during the past 12 months. Zoom out even further, and the three-year performance of 123% puts it solidly ahead of many market peers. The last month did bring a softer patch with a 5.7% pullback. Such moves often...